title: ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells.
abstract: Cyclin D1 is one of the major enhancers of cell cycle progression and its expression is regulated in several growth stimulatory signaling pathways. ARA54 is an androgen receptor (AR) co-activator that enhances AR-dependent transcriptional activation. Although expression of ARA54 mRNA is observed in a variety of human tissues at low levels, the AR- or androgen-independent function of ARA54 in those tissues remains unclear. In this study, we identified a novel role for ARA54 in the regulation of cyclin D1 expression in the absence of AR stimulation in human cancer cells. Depletion of endogenous ARA54 by small interfering RNA decreased both the protein and mRNA levels of cyclin D1. These changes did not result from a reduction in the half-life of either the protein or the mRNA, but from suppression of cyclin D1 gene transcription. In T98G cells, depletion of ARA54 increased the population of cells in G(1) phase, but reduced the population of cells in S phase, leading to a significant increase in the G(1)/S ratio and impaired cell growth. Furthermore, the amount of ARA54 mRNA appeared to positively correlate with cyclin D1 mRNA levels in specimens of clinical colon carcinomas, indicating that ARA54 is not only involved in the regulation of cyclin D1 expression in cultured cell lines but also in clinical cancer specimens. These results suggest that ARA54 might participate in enhancing cell cycle progression and cell proliferation via induction of cyclin D1.
authors.affiliation: Second Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu 431-3192, Japan.
authors.forename: Hirotoshi
authors.initials: H
authors.lastname: Kikuchi
authors.forename: Chiharu
authors.initials: C
authors.lastname: Uchida
authors.forename: Takayuki
authors.initials: T
authors.lastname: Hattori
authors.forename: Tomoyasu
authors.initials: T
authors.lastname: Isobe
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Hiramatsu
authors.forename: Kyoko
authors.initials: K
authors.lastname: Kitagawa
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Oda
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Konno
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Kitagawa
mesh_terms: D002453:Cell Cycle / Q000235:genetics; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D003110:Colonic Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D056741:Cyclin D; D016213:Cyclins / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology*; D005909:Glioblastoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D045325:HCT116 Cells; D006367:HeLa Cells; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D008297:Male; D012333:RNA, Messenger / Q000096:biosynthesis
chemical_list: D056741:Cyclin D; D016213:Cyclins; D047908:Intracellular Signaling Peptides and Proteins; D012333:RNA, Messenger; C118499:RNF14 protein, human